Delivery Order SPE2DB20D1004-SPE2DB22FF9G7
Award Date
7/18/22
Potential Completion Date
7/19/22
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $77,176.71 firm-fixed-price delivery order is for the pharmaceutical product Daliresp 500 mcg tablets. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Daliresp 500 mcg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a ceiling value of $11,812.39 and a firm fixed price. It has an ultimate completion date of September 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $6,809.75 Firm Fixed Price Delivery Order is for the supply of Daliresp 500 mcg tablets. The award was made on October 15, 2021, with a completion date of October 18, 2021. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,967.59 firm-fixed-price delivery order is for the supply of Daliresp 500 mcg tablets and has an ultimate completion date of August 19, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a critical vendor for the DLA, holding a substantial $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB20D2014|SPE2DB23FC11R, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,256.66 fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product, with a performance period through May 3, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award with ID SPE2DB22D1017|SPE2DB24FF3JR was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,509.05 firm fixed-price delivery order is for the pharmaceutical product Daliresp 500 MCG tablet, 90 count. This award is not designated as a set-aside contract. The contract has an ultimate completion date of February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Daliresp 250 mcg tablets to the Defense Logistics Agency (DLA). The $2,671.64 firm-fixed-price delivery order is the latest in a series of contracts between Amerisourcebergen and the DLA, with the company holding a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,118.73 firm fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of DALIRESP 500 MCG TABLET 30S. The contract has a ceiling value of $6,911.38 and a completion date of January 16, 2025. It is a firm fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,579.64 Firm Fixed Price Delivery Order covers the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...